tradingkey.logo
tradingkey.logo
Search

ICAD Inc

ICAD
Add to Watchlist
3.870USD
0.0000.00%
Close 07/02, 13:00ETQuotes delayed by 15 min
105.19MMarket Cap
LossP/E TTM

More Details of ICAD Inc Company

iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a 2D or 3D mammogram’s collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting, algorithmically examining a woman’s breast anatomy from the mammogram image.

ICAD Inc Info

Ticker SymbolICAD
Company nameICAD Inc
IPO dateDec 13, 1984
CEOMs. Dana R. Brown
Number of employees66
Security typeOrdinary Share
Fiscal year-endDec 13
Address98 Spit Brook Rd Ste 100
CityNASHUA
Stock exchangeEuronext Paris
CountryUnited States of America
Postal code03062-5737
Phone16038825200
Websitehttps://www.icadmed.com/
Ticker SymbolICAD
IPO dateDec 13, 1984
CEOMs. Dana R. Brown

Company Executives of ICAD Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Eric Lonnqvist
Mr. Eric Lonnqvist
Chief Financial Officer
Chief Financial Officer
1.40K
-6.16%
Ms. Dana R. Brown
Ms. Dana R. Brown
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Michael John Doyle
Mr. Michael John Doyle
Independent Director
Independent Director
--
-100.00%
Mr. Andrew H. (Andy) Sassine
Mr. Andrew H. (Andy) Sassine
Independent Director
Independent Director
--
--
Dr. Rakesh Patel, M.D.
Dr. Rakesh Patel, M.D.
Independent Director
Independent Director
--
-100.00%
Mr. Mark Koeniguer
Mr. Mark Koeniguer
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Jonathan Go
Mr. Jonathan Go
Chief Technology Officer
Chief Technology Officer
--
-100.00%
Dr. Hedvig Hricak, M.D., Ph.D.
Dr. Hedvig Hricak, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Susan Alyson Wood, Ph.D.
Dr. Susan Alyson Wood, Ph.D.
Independent Director
Independent Director
--
-100.00%
John Nesbett
John Nesbett
Investor Relations
Investor Relations
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Eric Lonnqvist
Mr. Eric Lonnqvist
Chief Financial Officer
Chief Financial Officer
1.40K
-6.16%
Ms. Dana R. Brown
Ms. Dana R. Brown
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Michael John Doyle
Mr. Michael John Doyle
Independent Director
Independent Director
--
-100.00%
Mr. Andrew H. (Andy) Sassine
Mr. Andrew H. (Andy) Sassine
Independent Director
Independent Director
--
--
Dr. Rakesh Patel, M.D.
Dr. Rakesh Patel, M.D.
Independent Director
Independent Director
--
-100.00%
Mr. Mark Koeniguer
Mr. Mark Koeniguer
Chief Commercial Officer
Chief Commercial Officer
--
--

FAQs

Who are the top five shareholders of ICAD Inc?

The top five shareholders of ICAD Inc are: Mr. Eric Lonnqvist

How many institutions hold shares of ICAD Inc (ICAD)?

As of 2025Q2, 117 institutions hold shares of ICAD Inc, with a combined market value of approximately 9.75M, accounting for 35.51% of the total shares. Compared to 2025Q1, institutional shareholding has increased by 1190732.00.

What is the biggest source of revenue for ICAD Inc?

In 2025Q2, the Subscription term licenses business generated the highest revenue for ICAD Inc, amounting to 1.78M and accounting for 36.62% of total revenue.